Navigation Links
Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía
Date:9/2/2014

aco que puede producir complicaciones graves para la vida, entre ellas la apoplejía. A pesar de la disponibilidad de tratamientos preventivos altamente efectivos, la apoplejía relacionada con la AF sigue siendo una importante y creciente carga clínica y social.

"Los últimos datos de GARFIELD-AF ilustran que la introducción de nuevas terapias ha comenzado a alterar la forma en que los pacientes de AF son tratados para prevenir la apoplejía", afirmó el profesor Lord Ajay Kakkar, profesor de Cirugía de la University College London y director de TRI. "La investigación previa ha demostrado que los resultados de pacientes pueden mejorarse cuando se utiliza la terapia anticoagulante apropiadamente. Sin embargo, las observaciones de la práctica clínica diaria en GARFIELD-AF sugieren que aún queda por hacer trabajo importante para asegurar que la implementación de la mejor práctica basada en evidencia, incluyendo la selección de pacientes adecuados para la anticoagulación y su tratamiento óptimo".

Los datos sobre el tratamiento preliminares para 31.666 pacientes de GARFIELD-AF reclutados en 34 países durante los primeros tres de cinco cohortes previstos se presentaron en un simposio satélite del ESC Congress 2014[2]. Desde el inicio de GARFIELD-AF en 2009, la aprobación normativa para NOACs incluyendo inhibidores de factor Xa (rivaroxaban, apixaban) y un inhibidor de trombina directo (dabigatran) ha alterado los patrones prescritos ofreciendo una alternativa a los antagonistas de vitamina K (VKAs), el estándar de cuidado establecido. El porcentaje de pacientes AF que recibieron un NOAC ha aumentado del 3,1 % durante el cohorte 1 (diciembre de 2009 a octubre de 2011) al 26,4 % durante la cohorte 3 (junio de 2013-junio de 2014). Sin embargo, el porcentaje de pacientes que recibieron cualquier anticoagulante sólo aum
'/>"/>

SOURCE GARFIELD-AF
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Adamas Pharmaceuticals presenta datos clínicos positivos para ADS-5102, un tratamiento para la disquinesia inducida por levodopa, en el Congreso Mundial del Parkinson
2. Enciclopedia online gratuita sobre el cáncer para la diagnosis y tratamiento del cáncer
3. Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke
4. One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines
5. EpiCast Report: Atrial Fibrillation - Epidemiology Forecast to 2023
6. Kalila Medical Announces CE Mark Approval For The Vado Steerable Sheath Used During Atrial Fibrillation Procedures
7. Daiichi Sankyo Submits Edoxaban Marketing Authorization Application to the EMA for Once-Daily Use for Stroke Prevention in Atrial Fibrillation and for the Treatment and Prevention of Recurrence of Venous Thromboembolism
8. Global Atrial Fibrillation Market Report 2013 - 2019
9. The Novel Oral Anticoagulants Will Continue to Drive Growth in the Atrial Fibrillation Drug Market
10. Daiichi Sankyos Once-Daily Edoxaban Meets Primary Efficacy Endpoint for Stroke Prevention and Superiority for the Principal Safety Endpoint Compared to Warfarin for Patients with Atrial Fibrillation in a Phase 3 Clinical Trial
11. Phase IIb Study of Vanoxerine Shows Strong Safety and Statistically Significant Efficacy Signals for Treatment of Atrial Fibrillation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)...  DURECT Corporation (Nasdaq: DRRX ) ... successful completion of a Phase 1 clinical trial ... is an endogenous, small-molecule, new chemical entity (NCE), ... such as nonalcoholic fatty liver disease (NAFLD) and ... such as acute kidney injury (AKI).        ...
(Date:3/2/2015)... March 2, 2015 BD (Becton, Dickinson and ... medical technology company, today announced the acquisition of CRISI ... medical technology company dedicated to improving the safety and ... position in helping address preventable medication errors and improve ... into an exclusive partnership in June 2013 to jointly ...
(Date:3/2/2015)...  Akron Children,s Hospital has been designated a Diagnostic ... of Radiology (ACR), making it the first hospital in ... hospital in the United States ... from the ACR as a DICOE provides validation that ... with national benchmarks," says Dr. Michael Rubin , ...
Breaking Medicine Technology:DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 2DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 3DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 4DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 5BD Acquires CRISI Medical Systems 2BD Acquires CRISI Medical Systems 3Akron Children's designated ACR Diagnostic Imaging Center of Excellence 2
...  Mission Pharmacal Company announces the recent formation ... unit, a wholly owned subsidiary of Mission, ... and human resources (HR) support.  Alamo will ... Northeastern United States presence, which also includes ...
... (NYSE: WPI ) today announced that ... a settlement with Mallinckrodt Inc. on outstanding patent ... Exalgo® (Hydromorphone Hydrochloride Extended-Release ) tablets.  Mallinckrodt filed ... United States District Court for the District of ...
Cached Medicine Technology:Mission Pharmacal Launches Alamo Pharma Services 2Mission Pharmacal Launches Alamo Pharma Services 3Watson Reaches Settlement with Mallinckrodt Over Exalgo(R) 2
(Date:3/2/2015)... March 02, 2015 Doctors in Novara, ... a better predictor of outcomes for people with mesothelioma ... details of the new study on the Surviving ... the University of Eastern Piedmont followed the cases of ... treatment for excess lung fluid. , “Persistent lung ...
(Date:3/2/2015)... 02, 2015 After a rigorous evaluation ... service, pricing and long-term strategy, Blood Centers of America ... choice for member centers’ testing needs. , BCA, which ... more than 30 percent of the U.S. blood supply, ... “BCA is committed to drive cost savings to members,” ...
(Date:3/2/2015)... Over the last five years the ultrasound market has ... their geographic presence and achieve economies of scale. The ... by 2019 at CAGR of 5.1% from 2014 to ... and a major part of Europe are mature markets ... including China and India, Latin America and the Middle ...
(Date:3/2/2015)... LegitScript, LLC, operator of ... including those for Internet pharmacy certification, monitoring ... classification, has launched a certification program for ... program, called iCareRx , provides certification ... identity of the owner/operator of Internet websites, ...
(Date:3/2/2015)... Pleasant Prairie, WI (PRWEB) March 02, 2015 ... life sciences consultancy focused on quality, regulatory and ... a role as Chief Operating Officer. , ... years of experience leading R&D teams in all ... has held leadership positions at Covidien (Medtronic), Regulatory ...
Breaking Medicine News(10 mins):Health News:New Research Links Talc Treatment Response with Mesothelioma Prognosis, According to Surviving Mesothelioma 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 3Health News:Therapeutic Ultrasound Devices Market worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets 2Health News:Therapeutic Ultrasound Devices Market worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets 3Health News:LegitScript Launches Certification Program for Internet Eyeglass Sellers 2Health News:Regulatory Compliance Associates® Inc. Welcomes Seyed Khorashahi as Chief Operating Officer 2
... The National Osteoporosis,Foundation (NOF) has partnered with CESLIE ... the LeFrak women - a dynamic mother-daughter trio ... dedication to,osteoporosis prevention. Joan Rivers, Melissa Rivers, Jill ... Walsh and Ceslie,Armstrong will host the cocktail soiree ...
... Charitable Contributions Decline Even Though Everyone Benefits ... And Don,t Forget to Claim The Deduction!, NEW YORK, April ... season, is a timely reminder that donating your car is,still a ... seem,to know that because the number of vehicle donations has plummeted ...
... policies could protect patients and physicians from consequences of ... offices and clinics can help prevent the abuse of ... following a stricter policy -- including urine testing --- ... , Implementing a user registry and educating medical staff ...
... British Columbia, April 10 On July,6, 2006, Current ... to the Chairman and to the Chief Executive,Officer, for ... capital of the Company, from his personal holdings, under ... total number of shares under option -- 3,000,000; ...
... Board Expanded to Seven Members, DALLAS, April ... leading healthcare staffing company, today said,that its Board ... (Jay),Dunn to its Board of Directors, effective immediately. ... seven members., John Kaiser, Crdentia,s President and ...
... Receive Grants from Largest and First-of-Its-Kind Fund in ... ... safety and quality of care, Cardinal Health announced,today grants totaling $1 million ... clinics across the country.,This program is the largest and first of its ...
Cached Medicine News:Health News:National Osteoporosis Foundation and CESLIE - The Women's Network Honor LeFrak Mother and Daughters for Commitment to Bone Health and New York Community 2Health News:Tax Season Reminder: Vehicle Donations Still Needed 2Health News:User Registry May Help Docs Stem Painkiller Abuse 2Health News:Keith Denner Extends Current Technology's Chairman and CEO Options 2Health News:Keith Denner Extends Current Technology's Chairman and CEO Options 3Health News:Crdentia Announces Appointments of David Jenkins and Raymond Dunn to Board of Directors 2Health News:Crdentia Announces Appointments of David Jenkins and Raymond Dunn to Board of Directors 3Health News:Cardinal Health Awards $1 Million to Fund Patient Safety Initiatives 2Health News:Cardinal Health Awards $1 Million to Fund Patient Safety Initiatives 3Health News:Cardinal Health Awards $1 Million to Fund Patient Safety Initiatives 4Health News:Cardinal Health Awards $1 Million to Fund Patient Safety Initiatives 5Health News:Cardinal Health Awards $1 Million to Fund Patient Safety Initiatives 6
... ACULAR® ophthalmic solution is a prescription ... instruct you to use after your ... eyes and may cause them to ... symptoms of inflammation include redness and ...
Mid-level interpretive resting ECG...
... II is a sterile nonpyrogenic, transparent viscoelastic ... II contains 12 mg/ml of high molecular ... hyaluronate dissolved in physiological saline. In the ... is 105,000 cps (105 Pa s) at ...
... Stat Profile pHOx series consists of six analyzer ... critical care profiles. Measured tests include pH, PCO ... hematocrit, hemoglobin, sodium, potassium, ionized calcium, chloride, glucose, ... than one minute. Its space saving design provides ...
Medicine Products: